MedTrace Logo

Extracorporeal Membrane Oxygenation Physical Training

NCT03328767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-05-08

No results posted yet for this study

Summary

Critically ill patients who require extracorporeal membrane oxygenation (ECMO) are the sickest in the hospital. More patients are surviving but survivors have compromised functional recovery for months or years. This trial aims to determine if early, physical training commenced within 48 hours of ECMO is feasible and improves muscle strength and functional status in patients compared to standard practice in a randomised controlled trial of 30 ICU patients.

Conditions

  • Critically Ill, Mechanically Ventilated
  • Extracorporeal Membrane Oxygenation Complication

Interventions

BEHAVIORAL

Early activity and Mobilisation intervention

The early activity and mobilisation intervention is comprised of exercises based on a reproducible, physiological approach using both strength and functional activities

Sponsors & Collaborators

  • Toronto General Hospital

    collaborator OTHER

  • Monash University

    collaborator OTHER

  • The Alfred

    collaborator OTHER

  • Royal Prince Alfred Hospital, Sydney, Australia

    collaborator OTHER

  • The Prince Charles Hospital

    collaborator OTHER_GOV

  • St Vincent's Hospital, Sydney

    collaborator OTHER

  • Australian and New Zealand Intensive Care Research Centre

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-19
Primary Completion
2020-02-01
Completion
2020-05-01

Countries

  • Australia
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03328767 on ClinicalTrials.gov